May 3, 2017
OptimizeRx Corp., a digital health aggregator of sponsored services in the electronic health records (EHR) space, has partnered with PARx Solutions to allow more than 500,000 healthcare providers in the OptimizeRx EHR network “to manage the prescription prior authorization process more effectively and efficiently.”
“In our cumbersome healthcare system, a physician often must spend considerable time and effort to obtain authorization from the insurance provider for a preferred prescription,” notes William Febbo, CEO of OptimizeRx. “Our new partnership with PARx Solutions addresses this problem, while providing connectivity to our core offering of financial messaging. Coupled with our ability to offer brand and clinical messaging services, we expect this combined solution to deliver better overall health outcomes—a core commitment of OptimizeRx.”
The partnership will involve the integration of OptimizeRx’s network of more than 370 EHR/eRx providers with PARx Solutions’ Prior Authorization Support System (PASS). The two companies say that integrating PASS into the physician’s EHR-powered work flow will reduce the administrative burden associated with the prior authorization process. It is also expected to increase adherence and improve patient outcomes by connecting OptimizeRx channel partners’ financial assistance offers with the prior authorization process.
Dan Rubin, president and CEO of PARx Solutions, says: “OptimizeRx is a natural fit with PARx Solutions, as their technology platform is very effective in how it directly connects to the e-prescribing work flow. The prior authorization process is a time-consuming and frustrating experience for prescribers, and often a hindrance to the quality of patient care. In fact, upwards of 40 percent of patients who require a prior authorization forego treatment altogether. We will now be better able to eliminate these barriers by providing a more simplified, user friendly process.”
The platform integration is expected to be completed in the third quarter of 2017. Like OptimizeRx services, PASS is sponsored by drug manufacturers, allowing the prior authorization service to be by provided at no cost to physician practices.
“Once the integration is complete, we see it significantly enhancing our value proposition to the remaining EHR/eRx providers and heath care providers not yet on our platform,” adds Febbo, “It will also deliver another valuable revenue stream for OptimizeRx.”
